ARUP’s test menu includes various tests to detect chromosomal rearrangements that are characteristic of specific types of sarcomas. For synovial sarcoma, ARUP offers a FISH-based test for the rearrangement of SS18 (SYT) for diagnosis, in addition to the PCR-based test for subtyping of the SYT-SSX t(X;18). For Ewing sarcoma, the lab offers an immunohistochemistry test for CD99, as well as a FISH-based for EWSR (22q12) rearrangement and a PCR-based test for the discrimination of the Type 1 and Type 2 forms of the EWS-FLI1 translocations.
  • Medical Director, Molecular Oncology
    Dr. Bernard is a professor of pathology at the University of Utah School of Medicine. He received his MD from and completed his postdoctoral training at the University of Utah and is certified in clinical pathology by the American Board of Pathology. Dr. Bernard’s laboratory at the Huntsman Cancer Center utilizes comprehensive genomic analyses to identify and translate biomarkers into clinical care for cancer patients. His work in gene expression classification of breast cancer led to the development of PAM50 (Prosigna), an FDA-approved diagnostic offered worldwide. His current research are in the development of liquid biopsies using ctDNA, CTCs, and exosomes for monitoring and early detection of cancer.
  • Chief, Division of Anatomic and Molecular Oncologic Pathology
    Dr. Bronner is a Carl R. Kjeldsberg presidential endowed professor of pathology at the University of Utah School of Medicine. Dr. Bronner received her MD from the University of Pennsylvania and completed her pathology residency training and chief residency at the Hospital of the University of Pennsylvania in Philadelphia. Dr. Bronner’s honors include her election as president of the GI Pathology Society, election as council member of the United States and Canadian Academy of Pathology, and, in 2005, the award of the Arthur Purdy Stout Prize, recognizing her work as a surgical pathologist under the age of 45 whose research publications have had a major impact on diagnostic pathology. Dr. Bronner is an editorial journal board member for Human Pathology and Modern Pathology. She has served as an investigator on numerous NIH and foundation grants over the course of her career and has published more than 100 peer-reviewed articles and numerous book chapters.
  • Medical Director, Anatomic Pathology
    Director, Anatomic Pathology Clinical Trials
    Director, Surgical Pathology Fellowship Program
    Dr. Liu is a professor of pathology at the University of Utah School of Medicine. Dr. Liu received her MD from Beijing University of Chinese Medicine and her MS in pathophysiology from Peking Union Medical College. She completed AP/CP residency training at Drexel University College of Medicine, a fellowship in hematology at Drexel University College of Medicine, and an oncologic/surgical fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Liu is an AP/CP and hematopathology-boarded pathologist. Her current research interests include oncologic clinical research.
  • Medical Director, Anatomic Pathology
    Dr. Samowitz is a professor of pathology at the University of Utah School of Medicine. He received his MD from SUNY Downstate, and completed residency training in anatomic pathology at the University of Chicago and fellowship training in gastrointestinal pathology at Johns Hopkins Hospital. His clinical and research focus is gastrointestinal pathology and the molecular genetics of colorectal cancer.